News
Oversight of the health insurance exchanges and the shift to value-based payments are the leading management challenges facing the Department of Health and Human Services in the coming year and the most concerning to the HHS Office of Inspector General.
Health plans are voluntarily extending the deadline to Jan. 10 for consumers to pay their first month's premium and still activate their coverage Jan. 1 in order to meet demand in escalating enrollment as federal and state exchange websites perform better.
Among the businesses eyeing the growing market for employer self-funding is one of Colorado's health systems, the University of Colorado Health.
The Department of Health and Human Services could improve Medicare quality through its clinical data registry program if it concentrated on performance measures, concluded a new federal report released this week.
A group of federally-qualified health centers in the Minneapolis area has broken the mold by creating the first safety-net ACO.
Less than a month before the new year, Minnesota joined three other states looking for a new health insurance exchange leader, after the first director, a former state economist and insurance company vice president, stepped down amid website dysfunction, a data breach and an ill-timed vacation.
Six years after the New York Department of Health started publishing hospital-acquired infection data as part of a public transparency agenda, the rates of most infections are trending downward, and benefiting health and financial outcomes.
Future hospital CEOs will have little to no healthcare experience suggests a report detailing developing trends impacting how headhunters will seek candidates.
Get ready, because data breaches are expected to rise in 2014, especially in the healthcare industry. New security threats and regulations that call for more transparency will be partly to blame.
In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs and will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market.